Optimal Saturated Neuropilin-1 Expression in Normal Tissue Maximizes Tumor Exposure to Anti-Neuropilin-1 Monoclonal Antibody
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
19
Page:
2269-2275
Author(s):
Chao Ma, Xiaofeng Dou, Jianghua Yan, Shengyu Wang, Rongshui Yang, Fu Su*, Huijuan Zhang* and Xinhui Su*
Integration and Querying of Heterogeneous Omics Semantic Annotations for Biomedical and Biomolecular Knowledge Discovery
Journal:
Current Bioinformatics
Volume:
15
Page:
41-58
Author(s):
Omer Irshad* and Muhammad Usman Ghani Khan
Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review
Journal:
Current Cancer Therapy Reviews
Volume:
16
Page:
5-18
Author(s):
Namrata Singh, Poonam Kushwaha*, Amresh Gupta and Om Prakash
Sam68 Promotes the Progression of Human Breast Cancer through inducing Activation of EphA3
Journal:
Current Cancer Drug Targets
Volume:
20
Page:
76-83
Author(s):
Xinxin Chen*, Lehong Zhang*, Min Yuan, Ziqiao Kuang, Ying Zou, Tian Tang, Wangjian Zhang, Xiaowu Hu, Ting Xia , Tengfei Cao and Haixia Jia
Ellipticine, its Derivatives: Re-evaluation of Clinical Suitability with the Aid of Drug Delivery Systems
Journal:
Current Cancer Drug Targets
Volume:
20
Page:
33-46
Author(s):
Vipin Mohan Dan, Thania Sara Varghese, Gayathri Viswanathan and Sabulal Baby*
C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular Carcinoma
Journal:
Current Cancer Drug Targets
Volume:
20
Page:
59-66
Author(s):
Zhuo Xu, Shao-Hua Meng, Jian-Guo Bai, Chao Sun*, Li-Li Zhao*, Rui-Feng Tang, Zhao-Lin Yin, Jun-Wei Ji, Wei Yang and Guang-Jun Ma
Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic
Journal:
Current Cancer Drug Targets
Volume:
20
Page:
3-18
Author(s):
Feng Gao* and Chun Yang
Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases
Journal:
Current Cancer Drug Targets
Volume:
20
Page:
19-32
Author(s):
Martyna Godzieba* and Slawomir Ciesielski
Possible Selective Cytotoxicity of Vanadium Complex on Breast Cancer Cells Involving Pathophysiological Pathways
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
19
Page:
2130-2139
Author(s):
Eman S. El-Shafey* and Eslam S. Elsherbiny
The Pharmacogenomics “Side-effect” of TP53/EGFR in Non-small Cell Lung Cancer Accompanied with Atorvastatin Therapy: A Functional Network Analysis
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
19
Page:
2060-2071
Author(s):
Lei Zhang, Yifang Huang, Xuedong Gan, Siying He, Xiaohuan Cheng, Na Yang, Siwei Li, Zuhua Li and Fang Zheng*